
Bambusa Therapeutics Taps Jonathan Lieber as New CFO
Jonathan I. Lieber, a veteran executive with over three decades of financial leadership in the life sciences sector, has joined Boston-based Bambusa Therapeutics as Chief Financial Officer. The appointment comes as the clinical-stage biotech firm looks to accelerate its pipeline of bispecific antibodies for immunology and inflammatory conditions.






















